A preliminary comparison of lidocaine and xylazine as epidural analgesics in ponies.

This research study investigated the comparative effectiveness and safety of Xylazine and Lidocaine as epidural analgesics in ponies. The results suggest that Xylazine provides a longer analgesia duration than Lidocaine, and neither drug led to noticeable pathological changes.

Study Design

• The researchers conducted a preliminary comparative study using six ponies for the evaluation of the effectiveness of two common epidural analgesics, Xylazine and Lidocaine.
• Each of the ponies was administered both the analgesics, Xylazine (0.35 mg/kg) and Lidocaine (0.35 mg/kg) in their epidural space, with a gap of one week between each treatment.
• The order in which the treatments were administered to each pony was randomized to eliminate bias and ensure scientific rigor.

Study Findings

• The vital outcome measured in the study was the duration of analgesia (pain relief). It was found that Xylazine provided a significantly more extended period of analgesia, with an average duration of around 247 minutes, compared with Lidocaine, which averaged about 135 minutes.
• Temporary mild ataxia, a condition that compromises the coordination of muscle movements, was observed in all the ponies. However, this was a transient effect, meaning it was temporary and waned off without requiring any intervention, making it clinically insignificant.

Study Safety Check

• To ensure safety, spinal cords were extracted from two ponies for histological examination. Histology is a microscopic examination of the biological tissues to study the effects of the treatment at the cellular level.
• The histological examination in this study revealed that there were no observable pathologic changes in the spinal cord tissues after the treatments. This finding suggests that both the treatments did not incite any detrimental effects at the cellular level in the spinal cord.

Conclusion

• This study indicates that Xylazine and Lidocaine, when used as epidural analgesics in ponies, do not lead to any apparent cellular changes in the spinal cord. Hence, they may be deemed safe based on these preliminary findings.
• Moreover, Xylazine appears to offer a longer duration of pain relief as compared to Lidocaine. However, further, more extensive studies may be required to cement these findings.